Table II. Treatment characteristics of neoadjuvant FOLFIRINOX.
| Treatment Characteristics | |
|---|---|
| Treatment Cycles | |
| Mean | 5 |
| 1-3, n(%) | 6 (29%) |
| 4-6, n(%) | 12 (57%) |
| ≥7, n(%) | 2 (10%) |
| Dose Reduction, n(%) | 6 (29%) |
| Treatment Delays, n(%) | 5 (24%) |
| Delay Duration, weeks (mean) |
1.5 |
| Admission During Tx, n(%) | 4 (19%) |
| Additional Treatment, n(%) | |
| Chemotherapy | 4 (19%) |
| SBRT | 12 (57%) |